BioPharm America™ 2012 capitalizes on thriving life science players in Boston
Carlsbad, CA and Boston, MA – April 23, 2012: EBD Group, the leading partnering firm for the life science industry, will hold the fifth annual BioPharm America™ September 19–21, 2012 in Boston, MA, at the Westin Boston Waterfront in collaboration with the Massachusetts Biotechnology Council (MassBio). Major pharmaceutical companies are confirmed to attend.
"MassBio is a strategic partner in bringing BioPharm America to the thriving life science sector in the Boston region," said Carola Schropp, President of EBD Group. "Boston is the right venue to cultivate potential partnerships based on its status as a world premier life science cluster. MassBio's continuing efforts to support the growth of the life science cluster in Massachusetts is a strong incentive for bringing the event back to Boston."
"BioPharm America is a highly productive partnering event, and as the leading advocate for Massachusetts' life science supercluster, MassBio hopes to continue providing value to our member community through engagement with this year's event," said Robert K. Coughlin, President and CEO of MassBio.
Major pharmaceutical companies are already committed to the event, with lead sponsorship from Takeda Pharmaceuticals, and other major sponsorships from AstraZeneca, Bayer HealthCare, Janssen, Merck, Novo Nordisk and Shire.
In 2011, BioPharm America had over 950 delegates from 588 companies taking part in 2,550 one-to-one partnering meetings facilitated by partneringONE®, the leading conference networking solution that combines the industry's most advanced web-based collaboration software with best practice implementation.